Volume : 11, Issue : 05, May – 2024
Title:
NASAL DRUG DELIVERY SYSTEM: A REVIEW
Authors :
Mohd Sajeed, Mohd Waqas
Abstract :
Therapy through intranasal administration has been an accepted form of treatment in the Ayurvedic system of Indian Medicine. In recent years many drugs have been shown to achieve better systemic bioavailability through nasal route than by oral administration . Advances in biotechnology have made available a large number of protein and peptide drug for the treatment of a variety of diseases. The nasal cavity is covered with a mucous membrane which can be divided into non-olfactory and olfactory epithelium areas. The non-olfactory area includes the nasal vestibule, which is lined with skin-like cells, and respiratory region, which has a typical airways epithelium .
Cite This Article:
Please cite this article in press Mohd Sajeed et al., Nasal Drug Delivery System: A Review., Indo Am. J. P. Sci, 2024; 11 (05).
Number of Downloads : 10
References:
1. Y.W. Chein, K.S.E. Su and S.F. Chang. “Nasal systemic drug delivery” Dekker, 1989, 1-77.
2. Proctor, D.F. The upper airways. I. nasal physiology and defense of the lungs, Am. Rev.Respir. Dis., 115:97(1977).
3. Maron, Z., Shelhamer, J., and Kaliner,M. nasal mucus secretion, Ear Nose Throat J.,63:36 (1984).
4. Gopinath, P. G., Gopinath, G., Anand Kumar, T.C. Target site of intranasally sprayed substances and their transport across the nasal mucosa:A new insight into the intra nasal route of drug delivery, curr. Ther. Res.23:596 (1978).
5. Blumgart, H.L. A study of mechanism of absorption of substance from the nasopharynx arch.Int med. 33:415 (1924).
6. Junginger “Bioadhesive polymer system for peptide delivery” Acta. Pharma. Tech., 1990, 36,110-126.
7. Cuana, N. Blood and nerve supply of the nasal lining, in THE NOSE: Upper Airway Physiology and the Atmosphere Environment.(1982), p.p.45-66.
8. Stovall, R., and Jackson, R. T. Prostaglandins and nasal blood flow, Ann.Otol. Rhinol. Lryngol. (1967).
9. Blumgart, H.L. A study of mechanism of absorption of substance from the nasopharynx arch.Int med. 33:415 (1924).
10. Beht et al. “Optimization of systemic nasal drug delivery with pharmaceutical excipients” Adv. Drug. Del. Rev, 1998, 29, 117- 133.
11. British national formulary, British medical association and Royal society of great Britain, London, 39,2000.
12. Schipper et al. “The nasal mucociliary clearance: relevance to nasal drug delivery” Pharma. Res., 1991,7,807-814.
13. Junginger “Bioadhesive polymer system for peptide delivery” Acta. Pharma. Tech., 1990, 36,110-126.
14. M.E. Aulton “ Pharmaceutics – The science of dosage form design” Churchill Livingston., 2002, 494.
15. Krishnamoorthy. R, Mitra. A. K “Prodrug for nasal drug delivery” Acta. Drug Del. Rev., 1998, 29, 135-146. Acta. Drug Del. Rev., 1998, 29, 135-146.